Skip to main content
    P

    P3 Health Partners Inc (PIII)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $2.41
    -0.29 (-10.74%)

    Last updated: Nov 16, 2026 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(10/21)
    Avg Surprise
    -46.01%
    Streak
    3 Q

    Upcoming Estimates

    Reports Mar 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$5.73
    Range-$6.90 - -$4.41
    4 analysts
    Revenue Consensus
    $412.39M
    Range$388.67M - $432.60M
    4 analysts
    Reports May 12, 2027 (est.)Period ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA10.45x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-6.55%Operating Margin10.70%
    ROE-192.60%ROIC-32.57%
    Financial Health
    Debt/Equity1.14xInterest Coverage-1.80x
    Current Ratio0.53xQuick Ratio0.53x
    Trading Statistics
    Beta1.80Avg Volume55.67K
    52-Week High$16.8952-Week Low$1.52

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 55.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 26.3, below 30, the oversold line.

    Moving Averages

    SMA 10$3.39
    SMA 20$3.72
    SMA 50$5.39
    SMA 200$6.59
    EMA 10$3.20
    EMA 20$3.73
    EMA 50$5.23
    EMA 200$6.82

    MACD

    Line: -0.73Signal: -0.69Hist: -0.04

    ADX

    ADX: 36.5+DI: 13.8-DI: 33.4

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$4.55

    Bollinger Bands

    Upper Band$4.93
    Lower Band$2.51
    %B Position6485%(Upper)
    Band Width-0.04

    RSI (14-Day)

    Oversold
    26.3

    Momentum Oscillators

    Stoch %K5.9
    Stoch %D6.7
    Williams %R-98.3
    ROC (10d)-39.7%
    Momentum-1.59
    CCI (20d)-191.5
    MFI (14d)10.8

    Volatility Measures

    ATR (14d)$0.50(20.6%)
    StdDev (20d)0.60
    Hist Vol135.7%(High)

    Volume Flow

    VWAP$2.48
    OBV70.3M
    AD Line22.5M
    CMF (20d)-0.458

    Volume Metrics

    Avg Vol (20d)57.6K
    Vol Ratio0.3x(Low)
    VWMA (20d)$3.39

    Pivot Points

    R3$3.14
    R2$2.97
    R1$2.84
    Pivot Point$2.67
    S1$2.54
    S2$2.37
    S3$2.24

    Advanced Oscillators

    TSI-40.43
    Ultimate Osc32.3
    KST-330.62

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about PIII

    News

    PIII Valuation

    EV/EBITDA
    10.4x
    P/B
    -0.1x
    All PIII metrics

    PIII Profitability: Margins, ROIC and FCF

    P3 Health Partners (PIII) has a gross margin of 100.0%, an operating margin of 10.7% and a net margin of -6.6%. It posts -32.6% ROIC and a -7.5% FCF margin.

    Gross margin
    100.0%
    Operating margin
    10.7%
    Net margin
    -6.6%
    ROIC
    -32.6%
    ROE
    -192.6%
    FCF margin
    -7.5%
    PIII financial statements

    PIII Bull Case vs Bear Case

    Bear case

    • PIII has a -6.6% net profit margin.
    • PIII beat EPS estimates in 37.5% of its last 8 reported quarters.

    PIII Earnings: Beat Rate and Next Report

    P3 Health Partners (PIII) beat the EPS estimate in 3 of the last 8 quarters (37.5%). Its next report is expected on Mar 24, 2027.

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -53.0%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$5.73
    PIII earnings history

    PIII Earnings Date

    PIII reports Mar 24, 2027. The date is estimated.

    PIII Earnings Call

    The latest PIII earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    PIII ETF Holders

    See insider activity

    Updated Nov 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About PIII

    When does PIII report earnings?

    P3 Health Partners Inc (PIII) is expected to report earnings on Mar 24, 2027.

    Does PIII pay dividends?

    P3 Health Partners Inc (PIII) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.